STING1 and neoplasm: Additionally, given the small sample size, Fisher’s exact test was used to compare the tumor cell-specific expression of STING against clinically relevant advanced stages of laryngeal cancer, grouping the tumor specimen stage IV against stages I to III and advanced pT3 and pT4 against pT1 and pT2.